Endexx Announces Global CBD License & Distribution Deal With Cannabis Infusion Brand the Mad Hatter Coffee & Tea Co.
Endexx has announced a license and distribution deal with The Mad Hatter Coffee & Tea Co., to deliver Cannabidiol (CBD) rich beverages that will be available globally.
The Mad Hatter Coffee & Tea Co. has led the niche market of cannabis-infused gourmet organic coffee and tea beverages since 2007, and is a true pioneer in cannabis-infused edible brands with beverage products currently available in 7 legalized states and over 2000 stores in the U.S. The Mad Hatter has been profiled by Newsweek, Time, The New York Times, and other major publications.
The collaboration offers a major opportunity to bring specific hemp and CBD-infused natural blends to the global health and whole foods markets, a major step for the cross-over markets valued at over $3 billion. As a result, Endexx will launch its first product to showcase the Third Eye Chai, a masala chai tea available in brew bags for individual use in multi-packs. In addition, the companies are in development for other bottled drinks and environmentally friendly K-cups.
Endexx CEO, Todd Davis, stated, “The Mad Hatter team and Endexx have been collaborating together for the past year. Their products are of the highest quality and exceed all expectations as a nutrition-based product to be infused with CBD and other phytonutrients. With the addition of our recently contracted Food Broker Network, we have positioned the company to be a leading distributor and product innovator in the hemp nutrition and health arena. Our studies of this plant-based naturally occurring molecule have demonstrated that both people and pets will achieve significant health benefits and noticeable changes in their daily lives.”
Jill Alikas St. Thomas, Cofounder of The Mad Hatter Coffee & Tea, said, “Our mission has always been to serve the patient. We research, design and expand our product lines for true patient needs and concerns. Joining forces with Endexx will allow Mad Hatter to broaden the reach of healthy alternatives into pharmaceuticals in a world ready to embrace proactive health practices. The analogous objectives we share with Endexx and their expertise of phyto-nutrients makes this a strong union.”